MO

Molecular Oncology

Molecular Oncology is an open access journal owned by FEBS. The journal considers Research Articles from the fields of basic, translational, and clinical cancer research and also publishes Review Articles, Commentaries and Policy Papers discussing emerging concepts in cancer research, cancer diagnosis, prevention and care. Manuscripts are handled by a team of dedicated academic Section Editors under a transparent peer review scheme.

Looking to publish in Molecular Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 4.5
Quartile Q2
Open Access Type Open
ISSN 1574-7891
eISSN 1878-0261
Invitation Only No
Cost Range APC: $4,730 USD / £3,170 GBP / €4,300 EUR; waived for Abstract, Commentary, Meeting Report, News, Perspective, and Practice and Policy.

Submission Instructions

Molecular Oncology accepts the following article types. Click on an article type to view submission instructions.

Research Articles

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required for Research Articles. Abstract must not exceed 180 words.
Manuscript A typical Research Article is around 5,500 words. Manuscript must use clearly defined and numbered sections and include Introduction, Materials and Methods, Results, and Conclusions, with a combined Results and Discussion section permitted. Manuscript must include a maximum of 6 keywords, a short author-contribution statement using initials only, acknowledgements before the references, a conflict of interest disclosure at the end of the main text, and any AI-use disclosure in the Methods or Acknowledgements as applicable.
References References must use a numbered citation system. References to in-press articles must include the article title and journal name, while unpublished work and personal communications should be cited only in the text.
Figures & Tables A typical Research Article contains 5–7 figures. Tables must be placed on separate pages at the end of the main text, while figures may be included in the main text file for review or provided as separate files at initial submission. Figure legends must be included in the main text, and tables must be submitted as editable text rather than images.
Reformat to Molecular Oncology using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must not exceed 180 words.
Manuscript Review Articles are recommended not to exceed 5,500 words. Manuscript must be divided into clearly defined and numbered sections. Manuscript must include a maximum of 6 keywords and figures summarizing key notions.
References References must use a numbered citation system. Review Articles should cite all primary literature.
Figures & Tables Review Articles should preferably contain 3–7 display items. Tables must be placed on separate pages at the end of the main text, and figures may be embedded in the main text for review or uploaded separately at initial submission. Tables must be submitted as editable text rather than images, and figure legends must be included with the main text.
Reformat to Molecular Oncology using Livewrite Premium

Systematic Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 180 words.
Manuscript Systematic Reviews should use a manuscript structure resembling that of Research Articles, with clearly defined and numbered sections. The manuscript must include an evaluation of the quality of analyzed evidence.
References References must use a numbered citation system.
Figures & Tables At initial submission, tables must be placed after the references and figures may be embedded in the main text file or uploaded separately. Tables must be submitted as editable text on separate pages at the end of the main text, and figure legends must be included in the main text rather than in the illustration files.
Reformat to Molecular Oncology using Livewrite Premium

Short Reports

Cover Letter A covering letter is required for Short Reports. The covering letter must state the reasons supporting immediacy of publication.
Abstract An abstract is required. The abstract must not exceed 180 words. The abstract is unstructured.
Manuscript Short Reports must not exceed 3,500 words. Short Reports use the same format as Research Articles, with clearly defined and numbered sections including Introduction, Materials and Methods, Results, and Conclusions, and a combined Results and Discussion section is permitted. Provide a maximum of 6 keywords, a short description of each author's contribution, a conflict of interest disclosure at the end of the main text, and any AI-use disclosure in the Methods or Acknowledgements as applicable.
References References must use a numbered citation system. Articles cited as in press must include the title and journal name, unpublished work should be kept to a minimum and cited in parentheses in the text, and personal communications may be mentioned only in the text.
Figures & Tables Short Reports may contain up to 4 display items in total, including figures and tables. At initial submission, tables must be placed after the references and figures may be embedded in the main text for review or uploaded as separate files. Tables must be submitted as editable text on separate pages at the end of the main text, and figure legends must be included with the main text rather than in the illustration files.
Reformat to Molecular Oncology using Livewrite Premium

A Guide To… Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must not exceed 180 words.
Manuscript Manuscript must be divided into clearly defined and numbered sections. Provide a maximum of 6 keywords, include a short description of each author's contribution at the end of the article, include a conflict of interest disclosure at the end of the main text, and disclose AI use in the Methods or Acknowledgements section as applicable.
References References must use a numbered citation system. In-press article references must include the article title and journal name, while unpublished work and personal communications should be mentioned only in the text.
Figures & Tables Tables must be placed on separate pages at the end of the main text, figure legends must be included in the main text, and figures may be embedded in the main text for review or submitted separately at initial submission. Tables must be submitted as editable text rather than images.
Reformat to Molecular Oncology using Livewrite Premium

Letters To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Letters to the Editor must not exceed 500 words. Letters to the Editor must include author contributions and a conflict-of-interest statement.
References Letters to the Editor may include up to five references. References must use a numbered citation system.
Figures & Tables Figures & Tables requirements are not specified.
Reformat to Molecular Oncology using Livewrite Premium

Recent Publications

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann

10.1002/1878-0261.70286
View Publication

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

Marcin Grochowski, Liudmyla Dolinchuk, Michał Jerzak, Albert Gandurski, Tomasz Grochowski, Weronika Wojtyś, Maciej Zadrożny, Wojciech Kaźmierczak, Małgorzata Lenarcik, Marta Matejak‐Górska, Radosław Samsel, Tomasz Olesiński, Dawid Walerych

10.1002/1878-0261.70282
View Publication

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park

10.1002/1878-0261.70285
View Publication

Correction to “Human papillomavirus ( HPV )‐18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein”

-

10.1002/1878-0261.70278
View Publication

Issue Information

-

10.1002/1878-0261.70287
View Publication

Frequently asked questions

How long does it take to publish?

Submission to first decision (median): 1 day; submission to acceptance (median): 121 days; acceptance to publication (median): 43 days.

Reformat to Molecular Oncology using Livewrite Premium

Is a cover letter required?

A cover letter is specifically required for Short Reports to explain the reasons supporting immediacy of publication. Fast-track submissions should include reviewer reports, editor comments, the final decision letter, and a point-by-point author response.

Reformat to Molecular Oncology using Livewrite Premium

What are the publication costs?

Article publication charge: $4,730 USD / £3,170 GBP / €4,300 EUR. No submission fees or page charges. APC waived for Abstract, Commentary, Meeting Report, News, Perspective, and Practice and Policy.

Reformat to Molecular Oncology using Livewrite Premium

Research Topics

Cancer Genomics and Diagnostics RNA modifications and cancer Cancer Cells and Metastasis Epigenetics and DNA Methylation Cancer-related molecular mechanisms research MicroRNA in disease regulation Cancer-related Molecular Pathways Cancer, Hypoxia, and Metabolism Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Ubiquitin and proteasome pathways Cancer-related gene regulation Genetic factors in colorectal cancer Pancreatic and Hepatic Oncology Research RNA Research and Splicing Human auditory perception and evaluation Educational Robotics and Engineering Diverse Scientific and Economic Studies DNA Repair Mechanisms Circular RNAs in diseases Prostate Cancer Treatment and Research PI3K/AKT/mTOR signaling in cancer Ferroptosis and cancer prognosis Immunotherapy and Immune Responses HER2/EGFR in Cancer Research

Related Journals

TI
Trends In Pharmacological Sciences Elsevier BV
BE
Biochimica Et Biophysica Acta-reviews On Cancer Elsevier BV
EC
Environmental Chemistry And Ecotoxicology Elsevier BV
JO
Journal Of Autoimmunity Elsevier BV
AI
Allergology International Elsevier BV
EA
Endocrinology And Metabolism Clinics Of North America Elsevier BV